Clinical trial
A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic…
NCT00266578 · Marc Rothenberg, Other · Completed
Key facts
| NCT number | NCT00266578 |
|---|---|
| Title | A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders |
| Official title | Effect of Swallowed Fluticasone Propionate on Eosinophilic Esophagitis; A Prospective, Randomized, Placebo-Controlled Trial |
| Lead sponsor | Marc Rothenberg, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Eosinophilic Esophagitis |
| Intervention type | Drug |
| Interventions | Fluticasone Propionate |
| Enrollment | 30 |
| Start date | Oct 1, 2002 |
| Primary completion | Nov 1, 2006 |
| Completion | Oct 1, 2012 |
| First posted | Dec 19, 2005 |
| Last update posted | Apr 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: